A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.
Some experts said the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Research also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.
After minutes of joining one group, a seller posted contact information, where most transactions take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Item Information and Costs
Inside these groups, posts show black plastic packages with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they can’t verify. Although the research behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to potentially serious health risks”.
